Project Grant R01AI193318
Award Date 8/22/25
Completion Date 7/31/30
Dollars Obligated $913K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94110, USA
Similar Awards
- This federal Project Grant award from the Department of Health and Human Services National Institutes of Health Office of the Director provided $14,427,699 to New York University School of Medicine for the period of May 24, 2021 through May 23, 2022. The award was made under the Lung Diseases Research program (CFDA #93.838) to support the POST-ACUTE SEQUELAE OF SARS-COV-2 INFECTION INITIATIVE: NYU LANGONE HEALTH CLINICAL SCIENCE CORE, DATA RESOURCE CORE, AND PASC BIOREPOSITORY CORE....
- This Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855) for $175,428.00 with an award date of Aug 1, 2025 and a final completion date of Jul 31, 2027. The grant supports research to investigate the mechanisms driving "Long COVID", the persisting and debilitating symptoms experienced by an estimated 400 million people worldwide after SARS-CoV-2 infection....
- This $2,112,000 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to Emory University supports research on understanding the impact of menstruation on cellular immunity against chlamydia and gonorrhea infections. The project aims to elucidate how the immune-mediated tissue remodeling process of menstruation compromises the immune response to these common sexually transmitted bacterial pathogens. The...
- This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 - Allergy and Infectious Diseases Research, provides $205,999 over 5 years to support a research program focused on understanding maternal-fetal immune interactions and the potential impact of environmental exposures on susceptibility to infection during pregnancy. The primary goal is to develop a cohort of young investigators with the skills to conduct high-quality...
- This Project Grant award for $107,995 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) is supporting research at Washington University to investigate the role of T cells in promoting post-acute memory deficits after COVID-19 infection in mice. The research aims to determine how systemic inflammation promotes recruitment of antigen-specific T cells to the central nervous system after SARS-CoV-2 infection, and how these T cells...
- This federal Project Grant award of $198,549 was provided by the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The purpose of the award is to investigate the synergistic effects of menopause and HIV on cardiovascular disease risk in women. The key products and services to be delivered include: Determining the association of HIV and menopausal phase with cardiovascular disease risk parameters such as insulin resistance, lipids,...
- This federal Project Grant award of $112,956.00 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research at Texas A&M University System Health Science Center to define the role of sex-specific traits in influencing the integration of immune and metabolic responses that impact infection susceptibility. The research will use the Drosophila melanogaster model to test the hypothesis that post-mating changes in...
- The federal Project Grant award of $654,367.00 was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The grant, awarded on January 1, 2025, supports research to investigate the neural mechanisms of fatigue in individuals with Post-Acute Sequelae of SARS-CoV-2 (PASC), also known as "Long COVID". The research aims to determine the relationship...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $200,016 to The Regents of the University of California, San Francisco (UCSF) to conduct a 5-year research program focused on elucidating the mechanisms by which certain children develop critical illness from SARS-CoV-2 infection. The key objectives are to: 1) Define and characterize the autoantibody repertoire in children with severe...
- This Project Grant award of $285,816 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) will support research to enhance understanding of ADP-ribosylation (ADPR) and its role in HIV-1 latency and reactivation. The awardee, The Regents of the University of California, San Francisco, will conduct biochemical, proteomic, and cellular assays to identify global proteomic changes to ADPR during HIV-1 latency and reactivation,...